FinanceCity

Divi's Laboratories Ltd. vs Sun Pharmaceutical Industries Ltd.

A side-by-side comparison of DIVISLAB and SUNPHARMA on the metrics that matter — size, valuation, profitability, leverage and ownership. Figures reflect the latest data refresh; always confirm against company filings.

MetricDIVISLABSUNPHARMA
Share price₹6,681₹1,798
Market cap₹1.77L Cr₹4.31L Cr
P/E ratio69.24x37.58x
P/B ratio10.57x5.17x
ROE16.19%14.72%
EPS (TTM)₹96.48₹47.86
Dividend yield0.45%0.89%
Debt / equity0.00x0.06x
Revenue₹10560 Cr₹58462 Cr
Net profit₹2568 Cr₹11480 Cr
Promoter holding51.88%54.48%

Common questions

Which is bigger, Divi's Laboratories Ltd. or Sun Pharmaceutical Industries Ltd.?+

Sun Pharmaceutical Industries Ltd. is the larger company by market capitalisation — about ₹4.31L Cr versus ₹1.77L Cr for Divi's Laboratories Ltd..

Which is cheaper by P/E, DIVISLAB or SUNPHARMA?+

Sun Pharmaceutical Industries Ltd. trades on the lower price-to-earnings ratio (37.58x vs 69.24x), though a lower P/E can reflect slower expected growth.

Which pays a higher dividend, Divi's Laboratories Ltd. or Sun Pharmaceutical Industries Ltd.?+

Sun Pharmaceutical Industries Ltd. currently shows the higher trailing dividend yield (0.89%).